Skip to main content
logo
Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.960
+0.030 (1.55%)
At close: Sep 18, 2026, 4:00 PM EDT
1.968
+0.008 (0.42%)
After-hours: Sep 18, 2026, 7:46 PM EDT

BDTX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
-----70--------------
Revenue Growth (YoY)
--------------------
Gross Profit
-----70--------------
Selling, General & Admin
4.664.263.973.544.14.965.985.229.576.75.577.866.886.817.246.286.987.896.427.74
Research & Development
7.3976.37.449.3210.5112.312.9112.5613.5515.2916.1513.1514.7514.6115.8516.217.7919.6627.63
Operating Expenses
12.0611.2610.2610.9813.4215.4718.2818.1322.1320.2520.8624.0120.0321.5621.8522.1223.1725.6826.0835.36
Operating Income
-12.06-11.26-10.26-10.98-13.4254.53-18.28-18.13-22.13-20.25-20.86-24.01-20.03-21.56-21.85-22.12-23.17-25.68-26.08-35.36
Interest & Investment Income
0.921.021.181.161.120.60.570.520.460.640.320.440.540.620.680.560.390.410.590.78
Earnings From Equity Investments
---------------2.25-----
Currency Exchange Gain (Loss)
-------------------0-
Other Non Operating Income (Expenses)
1.231.21.161.321.741.4212.061.760.450.310.570.340.170.2-0.09-0.14-0--0.49
EBT Excluding Unusual Items
-9.91-9.04-7.92-8.5-10.5656.54-16.71-15.56-19.91-19.16-20.22-23.01-19.15-20.77-23.23-21.65-22.93-25.28-25.5-35.08
Gain (Loss) on Sale of Investments
--0.15---0.73--0.930.81---0.11-0.08---0.23-0.37-
Gain (Loss) on Sale of Assets
--------------2.23-----
Asset Writedown
---7.35-----------------
Pretax Income
-9.91-9.04-15.12-8.5-10.5656.54-15.99-15.56-19.91-18.23-19.41-23.01-19.15-20.88-21.08-21.65-22.93-25.51-25.87-35.08
Net Income
-9.91-9.04-15.12-8.5-10.5656.54-15.99-15.56-19.91-18.23-19.41-23.01-19.15-20.88-21.08-21.65-22.93-25.51-25.87-35.08
Net Income to Common
-9.91-9.04-15.12-8.5-10.5656.54-15.99-15.56-19.91-18.23-19.41-23.01-19.15-20.88-21.08-21.65-22.93-25.51-25.87-35.08
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
5757575757575757555252513736363636363636
Shares Outstanding (Diluted)
5757575757585757555252513736363636363636
Shares Change (YoY)
0.99%-0.76%0.85%0.74%2.99%11.32%9.63%10.92%51.04%42.00%41.90%40.16%0.61%0.59%0.44%0.35%0.31%0.41%0.57%0.81%
EPS (Basic)
-0.17-0.16-0.26-0.15-0.191.00-0.28-0.28-0.36-0.35-0.38-0.45-0.52-0.57-0.58-0.60-0.63-0.70-0.71-0.97
EPS (Diluted)
-0.17-0.16-0.26-0.15-0.190.98-0.28-0.28-0.36-0.35-0.38-0.45-0.52-0.57-0.58-0.60-0.63-0.70-0.71-0.97
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-7.97-10.23-6.79-7.85-9.1653.41-15.06-11.32-14.73-21.2-13.96-18.4-14.37-20.03-21.94-16.47-18.26-28.61-24.38-27.97
Free Cash Flow Per Share
-0.14-0.18-0.12-0.14-0.160.93-0.27-0.20-0.27-0.41-0.27-0.36-0.39-0.55-0.60-0.45-0.50-0.79-0.67-0.77
Gross Margin
-----100.00%--------------
Operating Margin
-----77.90%--------------
Profit Margin
-----80.77%--------------
Free Cash Flow Margin
-----76.30%--------------
EBITDA
-12.03-11.23-10.2-10.89-13.3354.62-18.19-18.04-22.04-20.16-20.77-23.9-19.92-21.44-21.73-22-23.05-25.55-25.96-35.32
EBITDA Margin
-----78.02%--------------
D&A For EBITDA
0.030.030.070.090.090.090.090.090.090.090.090.120.110.120.130.130.130.130.120.04
EBIT
-12.06-11.26-10.26-10.98-13.4254.53-18.28-18.13-22.13-20.25-20.86-24.01-20.03-21.56-21.85-22.12-23.17-25.68-26.08-35.36
EBIT Margin
-----77.90%--------------
SEC Filings: 10-K · 10-Q